Diethylcarbamazine enhances antibody-mediated cellular adherence to Brugia malayi microfilariae
Open Access
- 1 December 1979
- journal article
- letter
- Published by Springer Nature in Nature
- Vol. 282 (5741) , 845-847
- https://doi.org/10.1038/282845a0
Abstract
Treatment with the antifilarial drug diethylcarbamazine (DEC) results in a rapid decline in the number of microfilariae circulating in the blood of infected hosts1. DEC induces morphological changes in the surface layers of microfilariae, but these alterations alone are probably insufficient to cause the death of the parasite, because the drug fails to reduce microfilaraemia in animals lacking filarial antibodies, and also does not shorten the survival of microfilariae in vitro1–4. The effect of DEC in vivo is thought to result from the trapping of microfilariae in the liver, where they undergo lysis1,2,5,6.Keywords
This publication has 6 references indexed in Scilit:
- Immune reactions in human filariasisJournal of Clinical Microbiology, 1978
- Onchocercal Dermatitis: Ultrastructural Studies of Microfilariae and Host Tissues, before and after Treatment with Diethylcarbamazine (Hetrazan®)The American Journal of Tropical Medicine and Hygiene, 1976
- Ultrastructural Changes in Litomosoides carinii Microfilariae in Gerbils Treated with DiethylcarbamazineJournal of Parasitology, 1968
- Observations with the Ultropak microscope on microfilariae of Litomosoides carinii circulating in the liver of a cotton-rat, before and after the administration of hetrazanTransactions of the Royal Society of Tropical Medicine and Hygiene, 1960
- Destruction of microfilariae of Loa Loa in the liver in loiasis treated with banocide (hetrazan)Transactions of the Royal Society of Tropical Medicine and Hygiene, 1951